Associated Papers
Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.
Judkins T et al.
Cancer Research, 2005
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.
Eerola H et al.
Breast Cancer Research : Bcr, 2005
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.
Eerola H et al.
International Journal of Cancer, 2001
Select a paper to view details